نتائج البحث

Preventing serious drug interactions.

• Authors : Meadows M

Subjects: Drug Interactions* ; Polypharmacy*; Anti-Allergic Agents/Anti-Allergic Agents/Anti-Allergic Agents/adverse effects

• Source: FDA consumer [FDA Consum] 2004 Jul-Aug; Vol. 38 (4), pp. 12-7.Publisher: Supt. of Docs., U. S. Govt. Print. Off Country of Publication: United States NLM ID: 0344327 Publication Model: Print Cited Medium: Print

تفاصيل العنوان

Preventing serious drug interactions

• Authors : Michelle, Meadows

Subjects: Food-Drug Interactions; Anti-Allergic Agents; Dietary Supplements

• Source: FDA consumer. 38(4)

تفاصيل العنوان

Medication Use and Older Adults.

• Authors : Meadows, Michelle

Subjects: *DRUG utilization; *OLDER people; *PAPER bags

• Source: FDA Consumer. Jul/Aug2006, Vol. 40 Issue 4, p20-26. 7p. 2 Color Photographs, 1 Graph.

تفاصيل العنوان

Committees reject OTC status for Tagamet, Rogaine.

Subjects: *HEARTBURN; *BALDNESS treatment; *DRUG interactions

• Source: FDA Consumer. Oct94, Vol. 28 Issue 8, p3. 1/3p. 1 Black and White Photograph.

تفاصيل العنوان

New drug treatment for Parkinson's disease.

Subjects: Indans/Indans/Indans/*therapeutic use ; Monoamine Oxidase Inhibitors/Monoamine Oxidase Inhibitors/Monoamine Oxidase Inhibitors/*therapeutic use ; Neuroprotective Agents/Neuroprotective Agents/Neuroprotective Agents/*therapeutic use

• Source: FDA consumer [FDA Consum] 2006 Jul-Aug; Vol. 40 (4), pp. 7.Publisher: Supt. of Docs., U. S. Govt. Print. Off Country of Publication: United States NLM ID: 0344327 Publication Model: Print Cited Medium: Print

تفاصيل العنوان

First depression patch approved.

Subjects: Depression/Depression/Depression/*drug therapy ; Monoamine Oxidase Inhibitors/Monoamine Oxidase Inhibitors/Monoamine Oxidase Inhibitors/*administration & dosage ; Selegiline/Selegiline/Selegiline/*administration & dosage

• Source: FDA consumer [FDA Consum] 2006 May-Jun; Vol. 40 (3), pp. 4.Publisher: Supt. of Docs., U. S. Govt. Print. Off Country of Publication: United States NLM ID: 0344327 Publication Model: Print Cited Medium: Print

تفاصيل العنوان

FDA asks Purdue Pharma to withdraw Palladone.

Subjects: Drug and Narcotic Control*; Alcohol Drinking/Alcohol Drinking/Alcohol Drinking/*adverse effects ; Analgesics, Opioid/Analgesics, Opioid/Analgesics, Opioid/*adverse effects

• Source: FDA consumer [FDA Consum] 2005 Sep-Oct; Vol. 39 (5), pp. 7.Publisher: Supt. of Docs., U. S. Govt. Print. Off Country of Publication: United States NLM ID: 0344327 Publication Model: Print Cited Medium: Print

تفاصيل العنوان

Two dietary supplements contain undeclared ingredient.

Subjects: Dietary Supplements/Dietary Supplements/Dietary Supplements/*adverse effects ; Piperazines/Piperazines/Piperazines/*adverse effects ; Vasodilator Agents/Vasodilator Agents/Vasodilator Agents/*adverse effects

• Source: FDA consumer [FDA Consum] 2005 Jan-Feb; Vol. 39 (1), pp. 6.Publisher: Supt. of Docs., U. S. Govt. Print. Off Country of Publication: United States NLM ID: 0344327 Publication Model: Print Cited Medium: Print

تفاصيل العنوان

Third drug for impotence.

Subjects: Carbolines/Carbolines/Carbolines/*therapeutic use ; Erectile Dysfunction/Erectile Dysfunction/Erectile Dysfunction/*drug therapy; Contraindications

• Source: FDA consumer [FDA Consum] 2004 Jan-Feb; Vol. 38 (1), pp. 4.Publisher: Supt. of Docs., U. S. Govt. Print. Off Country of Publication: United States NLM ID: 0344327 Publication Model: Print Cited Medium: Print

تفاصيل العنوان

Daily aspirin therapy.

Subjects: Aspirin/Aspirin/Aspirin/*adverse effects ; Platelet Aggregation Inhibitors/Platelet Aggregation Inhibitors/Platelet Aggregation Inhibitors/*adverse effects; Aspirin/Aspirin/Aspirin/administration & dosage

• Source: FDA consumer [FDA Consum] 2003 Sep-Oct; Vol. 37 (5), pp. 36.Publisher: Supt. of Docs., U. S. Govt. Print. Off Country of Publication: United States NLM ID: 0344327 Publication Model: Print Cited Medium: Print

تفاصيل العنوان